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Abstract.  This paper reports the isolation and charac- 
terization of Chinese hamster ovary cell mutants defec- 
tive in low density lipoprotein (LDL)-cholesterol 
trafficking.  The parental cell line was 25-RA, which 
possesses LDL receptors and various cholesterogenic 
enzyme activities that are partially resistant to down 
regulation by exogenous sterols (Chang,  T.  Y., and 
J.  S. Limanek.  1980. J.  Biol.  Chem.  255:7787-7795). 
Because these cells accumulate a large amount of in- 
tracellular cholesteryl ester when grown in medium 
containing  10%  fetal calf serum,  mutagenized popula- 
tions of 25-RA cells were grown in the presence of a 
specific inhibitor of acyl-coenzyme A: cholesterol 
acyltransferase (ACAT),  which depleted their 
cholesteryl ester Stores.  Without this cholesterol ester 
storage, 99 % of 25-RA cells die after 5-d growth in 
cholesterol starvation medium,  while the mutant cells, 
which accumulate free cholesterol intracellularly,  sur- 
vived. In two mutant clones chosen for characteriza- 
tion,  activation of cholesteryl ester synthesis by LDL 
was markedly reduced in the mutant cells compared 
with 25-RA cells. This lack of activation of choles- 
terol ester synthesis in the mutant cells could not be 
explained by defective uptake and/or processing of 
LDL or by a decreased amount of ACAT, as deter- 
mined by in vitro enzyme activity. Mutant cells grown 
in the presence of LDL contain numerous cytosolic 
particles that stain intensely with the fluorescent com- 
pound acridine orange,  suggesting that they are acidic. 
The particles are also stained with filipin,  a choles- 
terol-specific fluorescent dye. Indirect immunofluores- 
cence with a  monoclonal antibody specific for a 
lysosomal/endosomal fraction revealed a  staining pat- 
tern that colocalized with the filipin signal.  The mu- 
tant phenotype was recessive. The available evidence 
indicates that the mutant cells can take up and process 
LDL normally, but the hydrolyzed cholesterol accumu- 
lates in an acidic compartment,  probably the lyso- 
somes, where it can not be transported to its normal 
intracellular destinations. 
I 
s  mammalian  cells,  the enzyme responsible for intra- 
cellular cholesteryl ester synthesis,  acylcoenzyme A: 
cholesterol  acyltransferase  (ACAT)  ~ uses  cholesterol 
and fatty acyl coenzyme A as substrates  (18). In rat liver, 
ACAT has been localized to the rough endoplasmic reticulum 
(4, 30). In Chinese hamster ovary (CHO) cells and primary 
cultures of human fibroblasts,  ACAT activity is highly regu- 
lated by exogenous sources of cholesterol, such as low den- 
sity lipoprotein  (LDL) (16, 23, 26, 35), and by endogenous 
cholesterol synthesis  (15). All  available  evidence suggests 
that the enzyme is regulated by cholesterol at the posttransla- 
tional  level (10, 16, 23, 24, 26). The major mechanism  of 
regulation is probably the supply of the substrate cholesterol. 
In human fibroblasts, it has been shown that in order for LDL 
to exert its regulatory effects (i.e., down regulation  of LDL 
receptors and cholesterol biosynthesis and activation of ACAT 
activity), the cholesteryl ester moiety of the liproprotein, 
which forms the majority of the LDL cholesterol, must be 
1. Abbreviations  used in this paper:  ACAT, aeyl-coenzyme  A: cholesterol 
acyltransferase;  CT,  cholesterol  trafficking;  DIC,  differential  interference 
contrast; LDL, low density lipoprotein;  NP-C,  Niemann-Pick, type C. 
hydrolyzed by a specific acid lipase found in the lysosomes 
(26).  Presumably,  the free cholesterol then leaves the lyso- 
some,  and  in  the case of ACAT, activates  the enzyme by 
providing  an increased  amount of cholesterol  as substrate. 
The  mechanism  of transfer  of the  liberated  cholesterol 
from lysosomes to the ACAT enzyme is unknown. There are 
cellular proteins capable of transferring  hydrophobic  mole- 
cules between membranes in vitro.  One of these proteins, 
sterol  carrier  protein2,  has  been demonstrated  to activate 
ACAT activity in  vitro by stimulating  the transfer  of ex- 
ogenously added cholesterol  to the ACAT enzyme (25, 48). 
However, the physiological role of this protein in cholesteryl 
ester synthesis has not been established. 
Obtaining  mutants  in  which  cholesterol  movement  is 
defective would provide a valuable tool for defining intracel- 
lular cholesterol  transport pathways and serve as a first step 
towards identifying  the factors involved. It has been shown 
that  fibroblasts  isolated  from patients  with Niemann-Pick 
type C (NP-C) disease accumulate free cholesterol when in- 
cubated with LDL (36, 44). These fibroblasts bind and inter- 
nalize LDL at normal  rates,  and the LDL cholesteryl ester 
is  hydrolyzed  to  free  cholesterol.  However,  the  normal 
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pared  with unaffected fibroblasts  (37, 45).  This  has  been 
shown to be caused by a decrease in the rate of movement 
of LDL-derived cholesterol out of the NP-C lysosomes (38). 
Double  fluorescence  studies  with  the  cholesterol-specific 
stain  filipin and a monoclonal antibody directed against  a 
lysosomal membrane antigen have demonstrated colocaliza- 
tion of the accumulated intracellular  cholesterol with lyso- 
somes (7, 54). In addition, a strain of BALB/c mice with a 
neuropathological  condition  similar  to  NP-C  disease  has 
been described in which free cholesterol accumulates in the 
lysosomes (5, 40, 42,  52). 
In  this  report,  a  highly  efficient  selection  protocol  for 
isolating CHO cell mutants resistant to cholesterol starvation 
is described. Biochemical analysis showed that the mutants 
possess a phenotype similar to the one described for NP-C 
fibroblasts  (i.e., lack of activation  of ACAT by LDL despite 
an intact LDL receptor pathway, and an accumulation of free 
cholesterol upon growth in medium containing LDL). Cell 
hybridization analysis demonstrated that the phenotype of 
the two mutant clones examined was recessive and that they 
belonged to the same complementation group. Whether the 
genetic locus affecting these CHO cell mutants is the same 
as the one(s) corresponding to the NP-C disease awaits fur- 
ther genetic analysis. These mutants should serve as unique 
tools for cloning and identifying the gene affected via DNA 
mediated gene transfer (1). 
Materials and Methods 
Reagents 
[10-3H]Oleic  acid  and  ll,2,6,7-3H]chnlesteryl  linoleate  were  purchased 
from Du Font Company-Biotechnoiogy Systems (Wilmington, DE). Oleyl 
coenzyme A was synthesized as described by Stadtman using oleyl anhy- 
dride (55) and [3H]oleyl cocnzyme A was synthesized by another method 
(6).  Both preparations were quantitated as previously described (11, 12). 
Nal25I  (carrier free in 0.1  N  NaOH)  and Ha  [l-14C]  acetate were  from 
Amersham Corp. (Arlington Heights, IL). Compound 58-035 (3-[decyldi- 
methylsilyl-N-[2-(4-methylphenyl)-l-phenylethyi] propanamide)  was  pro- 
vided by Dr. John Heider (Sandoz Inc., East Hanover, NJ). Melvinolin was 
a girl from Alfred Alberts (Merck, Rahway, NJ). 25-hydroxycholesterol was 
purchased from Steraloids Inc. (Wilton, NH), dextran sulfate from Pharma- 
cia Inc. (Piscataway, NJ), and sodium taurocholate from Calbiochem Corp. 
(La Jolla, CA). Polyethylene glycol 4000 was obtained from EM Science 
(Cherry Hill,  NJ).  Chloroform,  methanol, and isopropanol used for the 
cholesterol analysis were  from Mallinckrodt Inc.  (Paris,  KY)  or Fisher 
Scientific Co.  (Pittsburgh,  PA)  and were  nanograde and spectranalyzed 
grade,  respectively.  FrTC-conjugated goat anti-mouse antibody was ob- 
tained from Cappeii Laboratories (Malveru, PA) (No. 1211-0081). The anti- 
body lgp58 was generously provided by Dr. Ira Mellman (Yale University 
School of Medicine, Department of Cell Biology, New Havea, CT). MOPC- 
21 antibody was a gift of Dr. Stanley C. Froehner (Department of Biochem- 
istry, Dartmouth Medical School, Hanover, NH). Cholesterol oxidase was 
generously  provided  by  Dr.  Albert  Chen  (Beckman  Instruments,  Inc., 
Fullerton, CA). Horseradish peroxidase (P-6140), cholesterol esterase (C- 
1892),  and phosphatidylcholine Type XI (P-2772,  lot 67F-8410) and all 
other enzymes and biochemical reagents were from Sigma Chemical Co. 
(St. Louis, MO). Other organic solvents and chemicals were from Fisher 
Scientific Co.  and were of reagent grade quality. 
Cell Culture 
All CHO cell lines described in this paper were grown as monolayers in 
tissue culture flasks or dishes purchased  from Costar  (Data Packaging 
Corp.,  Cambridge,  MA) or Falcon (Becton,  Dickinson &  Co.,  Lincoln 
Park, NJ). During the mutant selections all cells were maintained in F-12 
medium minus linoleic acid supplemented with antibiotics as previously de- 
scribed (11) plus 10% FCS (Sigma Chemical Co.). When delipidated FCS 
was  used,  it was  prepared  according to a  published procedure  (14),  as 
modified by Chin and Chang (22). After the mutant selections, all of the 
CHO cell lines used in this report were maintained on a  1:1 mixture of the 
above mentioned F-12 medium and MEM (Gibco Laboratories, Grand Is- 
land, NY) supplemented with 2 mM glutamine and antibiotics, plus  10% 
bovine calf serum  (Hyclone  Laboratories,  Sterile Systems,  Inc.,  Logan 
UT).  Delipidated bovine calf serum was made using Cab-o-sil (Eastman 
Kodak Co., Rochester, NY) as previously described (37). 
In this report (with the exceptions of Figs. 2 and 6), all experiments were 
performed with CHO cells that had been adapted to continuous growth in 
10% delipidated bovine calf serum in the F-12/MEM mixture. The adapta- 
tion (which took only one passage) and all subsequent platings were only 
successful when using tissue culture flasks or dishes from Falcon Labware. 
Upon plating of cells into the delipidated serum medium for the first time, 
most of the cells attached but looked unhealthy and grew very slowly.  After 
a few days, however, some of the cells (,~,10%) began to grow more rapidly. 
When these cultures reached confluency, they could be plated into fresh 
flasks where they attached, appeared healthy, and grew rapidly. 
Originally cultures were maintained in 10% delipidated serum. However, 
it was observed that occasionally the monolayers tended to clump together 
in patches. We subsequently found the clumping to occur less frequently 
when the concentration of delipidated serum was changed to 5 %. None of 
the data shown in this report were obtained from cultures with evident 
clumping. The human LDL (d --  1.019-1.063  g/mi) used in this report was 
prepared from plasma by sequential flotation in the presence of protease in- 
hibitors as previously described (11). 
Mutagenesis and Isolation of  Mutants 
The CHO cell clone 25-RA and the ACAT mutant AC29 were mutagenized 
with 125 ~tg/ml N-nitroso-N-ethyhrea as previously described (11). 5 d after 
mutagenesis, AC29 ceils were plated at a low density (1.5  ×  105 cells per 
20  ×  100 mm dishes)  in F-12  medium  plus  10%  FCS.  Because  large 
amounts of intracellular cholesterol ester interfered with the selection (see 
Results), mutagenized 25-RA cells were grown for 3 d in 10% FCS medium 
that contained the specific ACAT inhibitor, 58-035 (50) and then plated at 
low density in 10% FCS medium plus 58-035. The concentration of 58-035 
used (200 ng/ml) inhibits cholesteryi ester synthesis >98%  (11). 36-48 h 
after plating, the monolayers were washed twice with PBS and cultured in 
cholesterol starvation medium (F-12 medium plus 10% delipidated FCS, 35 
/~M oleic acid, 50 #M mevinolin, and 230 #M mevalonate). Mevinolin, a 
competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase 
(2), blocks synthesis of mevalonate and thus inhibits synthesis of steroidal 
and nonsteroidal isoprenoids. The small amount of mevalonate permits the 
synthesis of nonsteroidal isoprenoids (51). Medium changes were given on 
the 2nd, 3rd, and 4th d of growth in the cholesterol starvation medium. Af- 
ter 5-6 d almost all of the mutagenized 25-RA cells were dead or dying. 
At this time, the starved cultures were washed once with PBS and grown 
in 10% FCS medium plus 230 ~tM mevaionate. After an additional 5 d of 
growth, the largest colonies of surviving cells were located and potential 
mutants were identified by their distinct morphological appearance  (see 
Results). Colonies were removed using cloning rings and then recloned by 
limiting  dilution  in  10%  FCS  medium.  Sometimes,  depending on  the 
amount of nonmutant cell contamination in the populations removed with 
the cloning ring, it was necessary to subject the cells to another round of 
starvation selection before recloning. 
ACAT Assays 
Monnlayers were pulsed with a [3H]oleate/BSA solution and analyzed for 
incorporation of radiolabel into cholesteryi oleate as previously described 
(11, 12, 16). For the in vitro ACAT assays, cell homogenates were prepared 
by the hypotonic shock and scraping method (20) and used immediately. 
The microsomal assay has been described in detail previously (11, 16, 23). 
The reconstituted ACAT assay was performed as described in Cadigan and 
Chang (10). 
LDL Pathway A nalysis 
LDL was iodinated using iodine monochloride as described by Goldstein 
et al. (29). After incubation of the monolayers with the indicated amounts 
of 1251-LDL, the cells were assayed for dextran sulfate releasable and cell- 
associated  t25I-lipoprotein,  and the medium  was analyzed  for ~25IoLDL 
degradation as previously described (11). Specific binding and cell uptake 
were calculated by subtracting the nonspecific value, determined by assay- 
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from the total value (assayed with t25I-LDL alone). The nonspecific values 
ranged between 12 and 25% of the total value. 
For measurement of the hydrolysis and reesterification of LDL-derived 
cholesteryl linoleate, LDL was labeled with [1,2,6,7-3H] cholesteryl iinole- 
ate by the method of Roberts et al. (49), using the lipoprotein free fraction 
(d >1.215) of fresh human serum as the source of cholesterol ester exchange 
protein.  After  incubation  with  medium  containing  the  3H-cholesteryl 
linoleate-LDL, the cells were harvested in 0.2 M NaOH, neutralized with 
HCI,  and  the  lipids  extracted exactly  as  previously  described  for  the 
[3H]oleate  poise (11, 16).  Unlabeled cholesterol, cholesteryi oleate and 
cholesteryl linoleate were added as carriers. The extracted lipids were sepa- 
rated from one another essentially as described by Goldstein et al. (28). 
Briefly,  the extracted lipids were spotted in 80 #1 ethyl acetate onto Silica 
G  TLC  plates (Analteeh Inc.,  Newark,  DE)  impregnated with AgNO3. 
The TLC plates were impregnated by dipping into a 6.7% solution (metha- 
nol/H20; 2:1) of AgNO3 for 2 rain followed by air drying for 30 rain. The 
plates were then baked at 80"C for 1 h, cooled, and spotted. Plates were 
run in a benzene/hexane (1:1) solvent system, allowed to air dry overnight, 
sprayed with dichlorofluorescine (0.2% solution in ethanol), air dried, and 
visualized with short wave ultraviolet light to localize the relevant lipid spe- 
cies. The Rf values were: cholesterol ,~0.1; cholesteryl linoleate '~0.3; and 
cholesteryl oleate ,~.6, respectively. Bands were scraped and counted in 
the presence of Betafluor scintillation fluid.  An unidentified radioactive 
band (Rf 'x,0.75) was also found; its location on the plate made it likely that 
it was a cholesteryl ester with a saturated fatty acid moiety (28) and it was 
'~15% of the cpm found in the cholesterol oleate band. Since the ratio of 
the unknown band's cpm to the cholesterol oleate cpm remained roughly 
constant throughout the different conditions and different cell types, it was 
not included in the calculations of the data. Control experiments revealed 
an  average  recovery  of 60%  for  cholesterol,  cholesteryl  oleate,  and 
cholesteryl linoleate after extraction and TLC analysis. 
Microscopy 
Cells were grown on glass coverslips at a density of 5  x  104 cells per well 
in six well plates containing 1.5 mi of medium. It was found that the cells 
did not plate well on coverslips in medium containing delipidated bovine 
calf serum alone and it was necessary to plate in medium containing 0.5% 
bovine calf serum/4.5 % delipidated bovine calf serum. This concentration 
of bovine calf serum was not enough to induce the lipoprotein-dependent 
morphological changes described in this paper. I d after plating, the cultures 
were washed two times with PBS and changed to medium containing 5 % 
delipidated serum supplemented with 100 ttg/ml LDL (sometimes with 200 
ng/ml 58-035) or washed medium containing only delipidated serum. A 
medium change was given 2  d  after plating.  On day 3, coverslips were 
stained as indicated, mounted, and kept moist with Hanks balanced salt so- 
lution containing no phenol  red.  Immediately thereafter, the cells were 
viewed using a Zeiss universal microscope with either a 67x achromat oil 
immersion (Carl  Zeiss,  Inc.,  Thoruwood,  NY)  phase-contrast objective 
with differential interference contrast (DIC) optics or a 40X achrornat water 
immersion (Cart  Zeiss,  Inc.) phase-contrast objective. All micrographs 
were taken with TMAX-400 film (Eastman Kodak Co.) and developed ac- 
cording to instructions provided by the manufacturer. 
Acridine orange staining was carried out according to Poole (47). The 
monolayers were incubated for 30 min in the appropriate media containing 
10 tLg/ml acridine orange. Cells were then incubated for 15 min in medium 
lacking acridine orange before mounting the coverslips as described above. 
During the staining process, cells were kept in a 37°C, 5 % CO2 incubator. 
A 1 mg/ml stoek solution of acridine orange in DMSO was made fresh each 
time before use and diluted 100-fold  into media. Acridine orange fluores- 
cence was viewed with rhodamine fluorescence optics (No. 48 77 15; Carl 
Zeiss, Inc.). 
For the filipin staining, cells were washed four times with PBS and fixed 
with 4 ml of 10%  PBS formalin at room temperature for 1 h, rinsed four 
times with PBS, and stained with 1.5 ml of filipin solution for 1 h at room 
temperature (36) before washing and mounting for microscopy.  The filipin 
solution was made fresh each time by dissolving 2.5  nag filipin in  1 ml 
dimethylformamide and then diluting into 50 ml of PBS. The fixed cells 
were examined with a UV filter package (No. 48 77 02; Carl Zeiss, Inc.). 
When staining with the lysosomal/endosomal  antibody, lgp58, cells were 
first stained with filipin as described above,  lgp58 at 50--150 ~g/ml was 
diluted 50-fold into goat serum, spun in a microfuge for 30 s, and diluted 
another 50-fold into a 0.1% solution of saponin in PBS. This solution was 
used to label cells for 30 min at room temperature. Cells were washed exten- 
sively before labeling with an FITC-conjugated goat anti-mouse second an- 
tibody solution for 30 min at room temperature. The FITC-conjugated anti- 
body was diluted 500-fold into goat serum, spun in a microfuge for 30 s, 
and then diluted another 500-fold into 0.1% saponin in PBS before adding 
to the cells. Cells were rinsed with PBS and mounted for microscopy. Im- 
munofluorescence was examined with FITC-fluorescence optics (No. 48 77 
17; Carl Zeiss, Inc.). In control experiments, cells were labeled with lgG 
secreted by the myeloma cell line MOPC-21 at a similar concentfntion as 
with the antibody lgp58. 
Other Analytical Procedures 
Cellular cholesterol was determined using the fluorometric assay of Heider 
and Boyett (31) as described previously (12).: Cholesteryl ester was calcu- 
lated by subtracting the free cholesterol value from the total cholesterol 
value (determined after incubation of cellular lipids with cholesterol ester- 
ase). Cell hybridizations (11) and the [14Clacetate pulse (11, 19) were per- 
formed as described previously. All protein determinations in this paper 
were made using the Peterson modification (46) of the method of Lowry et 
al. (39); TCA precipitation was performed only when determining the pro- 
tein content of the cell extracts used for the in vitro ACAT assays. 
Results 
Isolation of Cholesterol Starvation Resistant Mutants 
The rationale for the ability of certain CHO cell mutants to 
survive cholesterol starvation is depicted in Fig.  1. The cho- 
lesterol  starvation  medium  consisted  of  10%  delipidated 
FCS plus 50 ~M mevinolin (to inhibit endogenous choles- 
terol synthesis) and 230/~M mevalonate (to permit the syn- 
thesis of nonsteroidal isoprenoids essential for cell growth; 
see  Materials  and  Methods).  When  grown  in  10%  FCS 
medium, 25-RA cells have previously been demonstrated to 
contain large amounts of cytosolic cholesterol ester droplets 
(11, 17). During cholesterol starvation, the hydrolysis of this 
cholesteryl ester apparently served as a reservoir of cellular 
cholesterol  for the 25-RA  cells,  enabling them to survive 
(Fig.l  a).  As shown in Fig.  2  b, 25-RA cells were able to 
grow for at least 5 d in the cholesterol starvation medium. 
In contrast, 25-RA cells treated with the specific ACAT in- 
hibitor 58-035  (or  ACAT  deficient  mutants derived  from 
25-RA cells) contain very little cholesteryl ester (11). Conse- 
quently, almost all of these cells die during cholesterol star- 
vation (Fig.  1 b  and Fig.  2  b).  The same result using the 
ACAT deficient mutant AC29 was found (data not shown). 
This cholesterol starvation procedure was originally de- 
signed for the isolation of revertants  of the ACAT deficient 
mutants.  However,  these attempts  were  not successful  be- 
cause of the high frequency of a novel class of mutants that 
were resistant to cholesterol starvation. Grown in 10% FCS, 
these mutants (designated as cholesterol trafficking, or CT 
mutants) possess intracellular particles that are distinct from 
the cholesteryl ester droplets seen in 25-RA cells. As will be 
demonstrated in the following sections, the CT mutants ac- 
cumulate a  large amount of unesterified cholesterol  when 
grown in medium containing 10% FCS or LDL. The storage 
of free cholesterol in a distinct cellular component enabled 
the CT mutants to survive the cholesterol starvation selection 
(Fig.  1 c). Three independent CT clones were isolated from 
three dishes (4.5  x  105 total cells) of mutagenized popula- 
tions of AC29 and 11 independent clones possessing the CT 
phenotype were isolated from  11  dishes (16.5  x  105 total 
cells) of mutagenized populations of 25-RA cells (pretreated 
with 58-035 to remove intracellular cholesteryl esters).  No 
CT mutants were found in four dishes (6  x  105 total cells) 
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Figure 1. Depiction of 25-RA cells (a), ACAT- 
deficient mutants from 25-RA, or 25-RA cells 
pretreated with 58-035, a specific ACAT  inhibi- 
tor (b), and CT mutants treated with 58-035 (c) 
during cholesterol starvation. After growth in 
10% FCS medium, 25-RA cells contain a large 
amount  of  intracellular  cholesteryl  esters, 
while ACAT-deticient mutants or 25-RA cells 
treated with 58-035 contain very little. During 
cholesterol starvation, the cholesteryl esters in 
25-RA  hydrolyzed  to  free  cholesterol  can 
maintain  a  sufficient level of cholesterol  for 
survival, Because they lack stored cholesterol, 
the ACAT-deficient  mutants and 58-035-treated 
25-RA ceils die in starvation medium. When 
grown in  10%  FCS medium the CT mutants 
contain a high level of intracellular free choles- 
terol.  This stored cholesterol pool apparently 
provides the mutants with enough cholesterol 
to survive the starvation. The ACAT inhibitor 
has no effect on the accumulation of this free 
cholesterol in the CT mutants. 
of unmutagenized 25-RA cells. The biochemical character- 
ization of two cholesterol trafficking clones derived from 25- 
RA cells, CT52 and CT60, is described in this report. 
As shown in Fig. 2 a, CT52 and CT60 pretreated with 58- 
035  grow at comparable rates to 58-035  treated 25-RA in 
10% delipidated serum, but unlike 25-RA they also grow in 
delipidated serum plus mevinolin and mevalonate (i.e., star- 
vation medium) (Fig. 2 b). These cell lines also retain resis- 
tance to the cytotoxic effects of 25-hydroxycholesterol (data 
not shown), a hallmark of  25-RA (19) and the 25-RA derived 
ACAT mutants (11). 
As mentioned above, CT52 and CT60 have a distinct mor- 
phological appearance when grown in  10%  FCS medium. 
The appearance of the various cell lines viewed with DIC op- 
tics is illustrated in Fig. 3. In delipidated serum (Fig.  3, a, 
d, and g) all three cell types had a similar appearance. When 
grown in delipidated serum plus  100/~g/ml LDL for 48 h, 
25-RA (Fig.  3 b) accumulated perinuclear droplets. These 
particles were similar to the ones previously observed in 25- 
RA grown in FCS medium and have been identified as cho- 
lesteryl esters (11, 12).  CT52 (Fig. 3 e) and CT60 (Fig. 3 h) 
ceils grown in LDL also have intracellular particles, which, 
unlike the droplets of 25-RA,  extended beyond the perinu- 
clear area. Using the DIC microscopy, the particles in both 
cell types appeared similar. However, if the cells were grown 
in LDL plus 58-035, the particles in 25-RA (Fig. 3 c) disap- 
peared completely, while only a minor reduction occurred 
in the amount of particles in CT52 (Fig. 3f) and CT60 (Fig. 
3 i). This indicates that the majority of particles in the CT 
mutants are not intracellular cholesteryl ester droplets de- 
rived as a product of the ACAT reaction. 
Cholesteryl Ester Synthesis and Cell 
Hybridization Analysis 
In pilot experiments (data not shown), it was found that the 
rate of cholesteryl ester synthesis in 25-RA cells grown in 
delipidated serum did not reach the low levels previously ob- 
served in this laboratory for wild-type CHO cells (16, 23). 
This was probably due to the high rate of endogenous choles- 
terol biosynthesis in 25-RA cells compared with wild-type 
cells  (11, 19).  The  addition  of  10  #M  mevinolin  to  the 
medium for 4 h before the pulse experiment using [3H]ole- 
ate reduced  [3H]cholesteryl ester synthesis from a  rate of 
12.7  :t:  1.6 pmol/min/mg to 2.9  +  1.1  pmol/min/mg (data 
not shown). Therefore, all the experiments described in this 
paper used media containing  10 #M mevinolin (as well as 
230 #M mevalonate) for the indicated times. 
As shown in Fig. 4 a, CT52 and CT60 cells have a greatly 
reduced activation of cholesteryl ester synthesis compared to 
25-RA cells as measured by [3H]oleate pulse after 6 h of in- 
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Figure 2. Growth of 25-RA (solid circles), CT52 (open circles), and 
CT60 (open squares) cells in delipidated serum medium with or 
without an inhibitor of cholesterol biosynthesis.  2.5  x  104 cells 
were plated in 9-cm  2 plates containing F-12 medium +  10% FCS 
and 200 ng/ml 58-035. After 48 h, the cultures were washed twice 
with sterile PBS and grown in F-12 medium supplemented with 
10%  delipidated  FCS  (a)  or  10%  delipidated  FCS  +  50  ttM 
mevinolin and  230 #M mevalonate (b).  Growth of 25-RA  cells 
without the 584)35 treatment are also indicated in b (solid squares). 
The  FCS  was  delipidated  using  Cab-o-sil  (see  Materials  and 
Methods).  The cultures were given fresh medium every day and 
were harvested in 0.2 M NaOH at the indicated times and aliquots 
were  taken  for protein  analysis  as  described  in  Materials  and 
Methods.  Values are the average of duplicate dishes and ranged 
within 5 % of the mean. 
The Journal of Cell Biology, Volume 110,  1990  298 Figure 3. Appearance of 25-RA (a-c), CT52 (d-f), and CT60 (g-i) cells viewed with DIC microscopy. 5  x  104 cells were plated on glass 
coverslips in 9 cm  2 plates as described  in Materials and Methods.  Some cultures were plated in the presence of 200 ng/ml 58-035 (c, f, 
and i). After 24 h, the cultures were washed twice with PBS and switched to medium containing 5% delipidated bovine calf serum alone 
(a, d, and g), supplemented with 100 #g/nil LDL (b, e, and h), or 100 #g/ml LDL +  200 ng/ml 58-035 (c,f, and i). Cultures were fed 
fresh medium at 48 h and coverslips were mounted and viewed with DIC microscopy at 72 h as described  in Materials and Methods. 
Bar, 20 #m. 
cubation with various concentrations of LDL. In a parallel 
experiment without  mevinolin,  LDL activated the  rate of 
cholesteryl ester synthesis (expressed as pmol/min/mg pro- 
tein) in 25-RA from 11.1 to 51.6; in CT52 from 15.5 to 24.8; 
and in CT60 from 17.5 to 23.8. Fig. 4 b shows the activation 
of cholesteryl ester synthesis upon the addition of increasing 
amounts of 25-hydroxycholesterol to the medium. This oxy- 
sterol activates ACAT independently  of the  LDL receptor 
pathway (26, 35). 25-hydroxycholesterol activated cholester- 
yl ester synthesis to a lesser degree than LDL, but the activa- 
tion was not defective in the CT mutants. The higher values 
observed in CT52 and CT60 compared to 25-RA cells may 
be due to their higher basal values in the absence of oxy- 
sterol. 
Fig.  5  examines  a  time  course  of  the  activation  of 
cholesteryl ester synthesis by LDL. Cholesteryl ester synthe- 
sis in the CT mutants was lower than 25-RA cells even after 
long periods  of incubation  with  LDL.  In the  experiment 
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Figure 4. Effect of LDL and 25-hydroxycholesterol  on the synthesis 
of cholesteryl esters in 25-RA (solid circles), CT52 (open circles), 
and CT60 (open squares) cells. Stock cultures were grown continu- 
ously in medium containing  delipidated  bovine calf serum for at 
least  two passages  as described in Materials  and Methods.  4  x 
105 cells were plated into 9 cm  e plates in medium containing  10% 
delipidated bovine calf serum. Medium was changed 48 h after plat- 
ing. 62 h after plating,  the cultures were changed to 10% delipi- 
dated serum medium +  10 #M mevinolin and 230/zM mevalonate. 
At  66  h,  the  same  medium  supplemented  with  the  indicated 
amounts  of LDL (a) or 25-hydroxycholesterol  (b) was added and 
6 h later, the monolayers were pulsed  with [3H]oleate for 30 min. 
After the pulse, the cells were harvested and analyzed for incorpo- 
ration  of radiolabel  into  cholesteryl  [3H]oleate  as  described  in 
Materials  and Methods. ValUes are the average of duplicate  dishes 
and ranged within  15% of the mean. 
shown in Fig. 5, the rate of incorporation of pH]oleate into 
triglycerides was found to be similar between all three cell 
types (data not shown). 
The  pH]oleate  pulse  provides  an  easy  and  quantitative 
method for distinguishing the 25-RA cell and the CT mutant 
phenotypes. All three cell lines were fused to a 25-RA cell 
clone bearing the azaguanine resistance (AG9 and ouabain 
resistance  (oua9 markers.  These genetic markers,  one re- 
cessive  (AG  r)  and  one  dominant  (oua9  make  these  cells 
"universal fusion donors" that can be used to obtain hetero- 
karyons with any cell type (3, 32). The hybrids were kept in 
selective medium until plating for the pH]oleate pulse and 
>95 % of the cells in each population had the characteristic 
large size seen withCHO/CHO cell hybrids previously ob- 
tained in this laboratory (11). As seen in Fig. 6 a, the unfused 
controls grown in delipidated serum  5:100 #g/ml LDL for 
6 h had rates of cholesteryl ester formation similar to those 
seen in Fig. 4. In contrast, the data shown in Fig. 6 b demon- 
strate that the cholesterol esterification in the hybrids were 
all activated to a similar degree as was observed with unfused 
25-RA cells. These data show that the phenotype of mutants 
CT52 and CT60 is recessive. 
In  addition,  complementation  analysis  was  performed 
using a CT60 cell line bearing the azaguanine- and ouabain- 
resistant markers as the fusion donor. When grown in 10% 
delipidated serum and then switched to medium containing 
100 #g/ml LDL, the CT60/25-RA hybrids increased their 
cholesteryl ester synthesis from 11.1 to 46.2 pmol/min/mg. 
The CT60/CT60 hybrid's rate of synthesis went from 20.5 to 
24.6 pmol/min/mg, and the CT60/CT52 hybrids from 13.2 
to 18.4 pmol/min/mg. Thus CT60 and CT52 appear to be- 
long to the same complementation group. 
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Figure 5. Time course of activation of cholesteryl ester synthesis  by 
LDL  in 25-RA (solid circles),  CT52 (open  circles),  and CT60 
(open squares) cells. Cells were plated as described in Fig. 4.4 h 
before the addition of LDL, the monolayers were switched to 10% 
delipidated  serum medium  +  10 #M  mevinolin and 230  #M 
mevalonate.  Cultures were switched to d¢lipidated  serum medium 
plus mevinolin,  mevalonate, and 100 #g/ml LDL at staggered times 
so that all the cultures could be pulsed  with [3H]oleate 72 h after 
plating.  All cells were fed the appropriate fresh medium at 48 and 
60 h after plating. After the pulse, the cells were harvested and ana- 
lyzed for incorporation of radiolabel  into cholestcryl [3H]oleatc as 
described  in Materials  and Methods.  Values arc the average  of 
duplicate  dishes  and ranged within  15% of the mean. 
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Figure 6. Cholesteryl ester synthesis in unfused CHO cells (a) and 
cell hybrids (b) grown in delipidated  serum (solid bars) or delipi- 
dated serum plus LDL (hatched bars). Hybrids were prepared by 
fusing the indicated cell clones with the 25-RA cells that bear the 
azaguanine  resistant  and ouabain resistant  markers (11). 5  ×  104 
unfused  controls and  7.5  ×  104 hybrids  were  plated  in  9  cm  2 
dishes  containing medium plus 10% FCS.  After 48 h, the mono- 
layers were washed twice with PBS and switched to medium plus 
10% delipidated  FCS. Fresh medium was given 24 h later. At 86 h 
after plating, the cultures were changed to delipidated FCS medium 
plus  10 #M mevinolin and 230 #M mevalonate.  At 90 h, the cells 
were given the above medium  +  100 #g/ml LDL and grown for 
an additional  6 h before  being pulsed  for 30 min with  [3H]ole- 
ate. Incorporation of radiolabel  into cholesteryl [3H]oleate was de- 
termined as described in Materials  and Methods.  Values are the av- 
erage of duplicate  dishes  and ranged  within  15% of the mean. 
We next examined the in vitro ACAT activity in the rele- 
vant cell lines (Table I). The microsomal ACAT assay, like 
the  [3H]oleate pulse,  utilizes cellular cholesterol as one of 
the ACAT substrates. The values obtained from cell homog- 
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and Reconstituted ACAT Activity of  25-RA, CT52, 
and CT60 Cell Extracts 
ACAT specific activity 
Cell type  Time in LDL  Microsomal  Reconstituted 
h  pmol/min/mg 
25-RA  0  18.9  82.3 
2  115.3  104.0 
48  131.5  98.7 
CT52  0  25.1  136.6 
2  45.3  142.6 
48  98.0  154.2 
CT60  0  19.8  78.6 
2  29.4  87.1 
48  174.4  94.0 
3  x  10  ~ cells were plated in 75 cm  ~ flasks in 12 ml of medium and grown un- 
der identical conditions as described in Fig. 5. LDL was added to the cultures 
at the indicated times, 72 h after plating, the monolayers were harvested and 
the microsomal and reconstituted ACAT activities of the cell extracts deter- 
mined as described in Materials and Methods.  Values are the average of dupli- 
cate aliquots taken from each cell extract and ranged within 10% of the mean. 
enates harvested after 2 h growth in LDL are reminiscent to 
those shown in Fig. 5, i.e., the CT mutants are defective in 
the activation of ACAT. However, the activities found from 
the extracts prepared from cultures grown in LDL containing 
medium for 48 h did not reflect the values obtained in the 
[3H]oleate pulse.  Under these conditions, and when cells 
are grown continuously in FCS medium (data not shown), 
the ACAT activities are as high or higher in the CT mutants 
compared with 25-RA. 
Since the [aH]oleate pulse and microsomal ACAT  assay 
rely on cellular cholesterol, the results of these assays are 
influenced by the amount of cholesterol surrounding ACAT 
in addition to the absolute amount of enzyme. Therefore, 
reconstituted ACAT  assays,  where the  enzyme activity is 
solubilized and then reconstituted into cholesterol-phospha- 
tidylcholine vesicles of a  defined concentration (10)  were 
performed. There was no difference found between recon- 
stituted ACAT activities in the cell extracts obtained from 
each cell line grown with or without LDL (Table I). This is 
consistent with previous work from this laboratory (10, 15, 
16, 23) that suggested that changes in the ACAT protein con- 
tent are not responsible for the regulation of enzyme activity 
by LDL. The reconstituted ACAT activities in CT60 and 25- 
RA cell extracts were found to be similar but the recon- 
stituted ACAT activities in CT52 cell extracts were always 
'~50% greater than values obtained with 25-RA cell extracts. 
Since the mutants were isolated from mutagenized cells, it 
is possible that the CT52 mutant may contain a separate mu- 
tant locus, irrelevant to the CT locus addressed in this report, 
which may cause elevated ACAT activities in this particular 
cell line. Other possibilities can not be excluded. The data 
clearly show that in vitro ACAT activity is present in the CT 
mutants in normal or greater than normal amounts. 
LDL Receptor Pathway Analysis 
The binding,  internalization,  and degradation of '2~I-LDL 
was examined in 25-RA and the CT mutants (Fig. 7). The 
specific binding (Fig. 7 a) and internalization (Fig. 7 b) in 
the CT mutants were found to be ,x,l.6-2.0-fold higher than 
that of 25-RA cells.  Total degradation of the radiolabeled 
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Figure 7. The specific binding (a), specific internalization (b), and 
total degradation (c) of ~2~I-LDL in 25-RA (solid circles), CT52 
(open circles), and CT60 (open squares) cells. Cells were plated 
and grown as described in Fig. 4, except that 5 % delipidated serum 
was used.  At 66 h after plating, media containing the indicated 
amounts of ~25I-LDL (343 cpm/ng) were added to the cells. After 
6 h, the cells were analyzed for specific binding and internalization, 
and total degradation of the  ~I-LDL as described  in Materials 
and Methods. Values are the average of duplicate dishes and ranged 
within 10% of the mean. 
LDL was also measured (Fig. 7 c). Controls demonstrated 
that the addition of a large excess of unlabeled LDL (500 
/zg/ml)  inhibited the degradation of the  ~2SI-lipoprotein by 
82-93 %, and the presence of 100/zM chloroquine, an inhib- 
itor of lysosomal function (26, 28), did not block internaliza- 
tion but resulted in a 71  to 90%  reduction in degradation 
(data not shown).  Degradation of radiolabeled LDL in the 
CT mutants was similar or slightly higher than levels found 
in 25-RA cells. 
Besides the degradation of  the LDL protein moiety, the hy- 
drolysis of LDL-cholesterol ester also occurs in the lyso- 
somes, via a specific acid lipase (26, 28). Of the total choles- 
terol in LDL, 75-80% is estedfied (53), and the hydrolysis 
of this sterol ester is necessary for the regulatory effects of 
LDL to be observed in human fibtoblast (26, 28) and CHO 
cells (22). By labeling the LDL with [3H]cholesteryl linole- 
ate, it is possible to measure the hydrolysis of [3H]choles- 
teryl linoleate to free [3H]cholesterol. 
The data  in  Fig.  8  illustrate the  total  LDL-[3H]choles  - 
teryl linoleate hydrolyzed (Fig.  8 a) and the LDL derived 
[3H]cholesteml that is reesterified (Fig. 8 b) after addition of 
[3H]cholesteryl linoleate-LDL to the cultures. CT52 cells hy- 
drolyzed, on average, 2.1  times more LDL-[3H]cholesteryl 
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Figure 8. Hydrolysis (a) and reesterification (b) of LDL-[3H]cho  - 
lesteryl linoleate in 25-RA (solid circles), CT52 (open circles), and 
CT60 (open squares) cells.  Cells were plated and grown as de- 
scribed  in Fig. 7, except that after 62 h, all media were supple- 
mented with 35 #M oleic acid. At 66 h after plating, medium con- 
mining  the  indicated  amounts  of [3H]cholesteryl linoleate-LDL 
(3,180 cpm/nmol cholesteryl linoleate) were added to the cells. Af- 
ter 6 h, the cells were harvested and the lipid extracts were analyzed 
for [3H]cholesterol, [3H] cholesteryl linoleate, and [3H]cholesteryl 
oleate as described in Materials and Methods. Hydrolysis of LDL- 
[3H]cholesteryl linoleate was calculated by addition of the [3H]cho- 
lesterol and [3H]cholesteryl oleate values. The amount of reesterifi- 
cation  of LDL-[3H]cholesterol was calculated  from the  [3H]cho- 
lesteryl oleate values. Values are the average of duplicate plates and 
ranged within  10% of the mean. 
linoleate than 25-RA cells, while CT60 hydrolyzed between 
50 and 140% of the values found for 25-RA. Despite this rel- 
atively normal or greater than normal hydrolysis of LDL- 
[3H]cholesteryl linoleate in the CT mutants, they reesterified 
11-19  times more LDL derived [3H]cholesterol than CT52 
and CT60 cells. 
Control experiments similar to the ones performed during 
the  '2q-LDL experiment demonstrated that the amount of 
LDL-[3H]cholesteryl linoleate hydrolyzed by the cells was 
inhibited 66-87 % by excess unlabeled LDL. The addition of 
chloroquine to the medium caused a drastic increase in the 
amount of [3H]cholesterol linoleate found in the cells and a 
large decrease  (73-88%)  in  the  percentage of radiolabel 
found  in  the  [3H]cholesterol  and  [3H]cholesteryl  oleate 
bands (data not shown). 
Sterol Analysis 
The data shown in Fig. 8 indicates that the cholesteryl ester 
moiety of LDL is hydrolyzed normally in the CT mutants but 
unlike  the  parental  cell  line  25-RA,  the  cholesterol  is 
reesterified at a much diminished rate. To address the ques- 
tion of what happens to this liberated cholesterol, sterol anal- 
ysis of 25-RA and the CT mutants was performed. Fig. 9 il- 
lustrates the changes in sterol content with increasing time 
(3-72  h)  after the  addition  of  100  ~g/ml  LDL.  The  un- 
esterified cholesterol level of the 25-RA cells remained rela- 
tively unchanged while the presence of LDL in the medium 
caused a  large accumulation of cholesteryl ester in 25-RA 
cells and a  smaller increase in the CT mutants, consistent 
with the activation of cholesteryl ester synthesis shown ear- 
lier (Figs.  4-6).  In contrast,  both CT mutants exhibited a 
dramatic time dependent increase in their cellular choles- 
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Figure 9. Time course of cholesterol (a) and cholesteryl ester (b) 
accumulation after addition of LDL. 25-RA (solid circles), CT52 
(open circles), and  CT60 (open squares) cells  were plated and 
grown exactly as described in Fig. 5 except that 5 % delipidated se- 
rum was used throughout the experiment. At 72 h after plating, the 
cultures were harvested and analyzed for cholesterol and choles- 
teryl ester as described  in Materials and Methods. Values are the 
average of duplicate aliquots taken from cell extracts and ranged 
within 5 % of the mean. 
terol content, which reached at maximum 4.5-5.0-fold above 
the levels observed in the absence of LDL. This accumula- 
tion was also dependent on the concentration of LDL in the 
medium and was seen when the cells were grown in the pres- 
ence of the ACAT inhibitor 58-035  (data not shown). 
In  a  parallel  experiment  to  the  one  shown  in  Fig.  9, 
mevinolin was not included in the growth medium, and very 
similar results were obtained (data not shown),  suggesting 
that endogenous synthesis of cholesterol did not contribute 
significantly  to  the  accumulation  of cellular  cholesterol. 
Therefore,  the  large  majority  of accumulated  cholesterol 
seen in the CT mutants must have come directly from LDL. 
Localization of the Accumulated 
IntraceUular Cholesterol 
The accumulation of free cholesterol and the defective acti- 
vation of cholesteryl ester synthesis after LDL addition in the 
CT  mutants  is  very  similar  to  the  observations  made  in 
fibroblasts isolated from a strain of BALB/c mice with a neu- 
rological disorder (43), and human fibroblasts isolated from 
patients  with  NP-C  disease  (36,  44).  Cells  from  these 
affected mice and humans have been shown to accumulate 
free cholesterol in their lysosomes in response to exogenous 
sterols such as LDL (5, 7, 38, 52, 54). Both CT52 and CT60 
have been shown to accumulate a large amount of dark intra- 
cellular particles (Fig. 3) and free cholesterol (Fig. 9) when 
grown  in the  presence of LDL.  It seemed that  these  two 
phenomena were linked, and the similarity between the CT 
mutants and the NP-C and mouse fibroblasts suggested that 
the cytoplasmic particles in the CT mutants may be lysosomes 
full of cholesterol. 
The fluorescent stain acridine orange is a membrane per- 
meant weak base that accumulates in acidic cellular com- 
partments (47) where it emits red light (>620 nm) upon exci- 
tation. As seen in Fig. 10, g and h, CT52 cells grown in LDL 
before acridine orange staining contain a fluorescence signal 
pattern that colocalized with the dark cytoplasmic particles 
The Journal of Cell Biology, Volume 110,  1990  302 Figure 10. Localization of acidic compartments with acridine orange in 25-RA (a-d) and CT52 (e-h) cells. Cells were grown as described 
in Fig. 3 in medium containing 5% delipidated serum (a, b, e, and f) or medium containing 5% delipidated serum supplemented with 
100 #g/ml of LDL (c, d, g, and h). Cells were stained with acridine orange as described in Materials and Methods before viewing with 
phase-contrast (a,  c, e, and g) or fluorescence (b, d, f, and h) microscopy. Bar,  20 t~m. 
visualized with phase-contrast microscopy. In contrast,  the 
lighter, perinuclear particles seen in the 25-RA cells treated 
with LDL did not colocalize with the acridine orange signal 
(Fig.  10, c and d). For CT52 cells, there was a large increase 
in  the  amount  of acridine  orange  signal  in  cells  grown  in 
LDL-containing medium compared to cells grown in delipi- 
dated serum medium alone (Fig.  10, fand  h),  while no in- 
crease  was  observed  in  25-RA  cells  (Fig.  10,  b  and  d). 
Cadigan et al.  ClIO Cells Defective in Cholesterol  Trafficking  303 Figure 11. Localization of intracellular  cholesterol  with filipin in 25-RA (a-d) and in CT52 (e-h) cells.  Cells were grown as described 
in Fig.  3 in medium containing 5% delipidated  serum (a, b, e, and f) or medium containing  5% delipidated  serum supplemented  with 
100 ttg/ml of LDL (c, d, g, and h). ,Cells were fixed and stained with filipin as described in Materials  and Methods before viewing with 
phase-contrast  (a,  c, e,  and g) or fluorescence  (b, d, f, and h) microscopy.  Bar,  20/zm. 
Results  similar to those seen  in CT52 cells  were obtained 
with mutant CT60 (data not shown). To rule out the possibil- 
ity that acridine orange is partitioning into a  nonacidic site 
within the call, the weak base ammonium chloride was used 
to neutralize the lysosomes/endosomes. When cells were in- 
cubated for 45 rain with 50 mM ammonium chloride before 
staining with acridine orange, the staining pattern seen in the 
presence of LDL was abolished (data not shown). The cells 
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thus the fluorescence pattern seen in Fig.  10 would appear 
to be from the accumulation of  acridine orange in the cellular 
acidic compartments. 
When CT52 cells were grown in LDL and stained with 
filipin, a fluorescent compound known to bind specifically 
to  cholesterol  (8),  a  strong  filipin  signal  was  seen  that 
colocalized with dark perinuclear particles (Fig.  11, g  and 
h).  In contrast, the modest amount of filipin staining ob- 
served in 25-RA cells grown in LDL (Fig.  11, c and d) did 
not colocalize with its cytosolic, lipid droplet particles. As 
with the acridine orange staining experiment, after addition 
of LDL, there is a large increase in filipin fluorescence in 
CT52 mutants compared to CT52 grown in delipidated se- 
rum alone (Fig.  11, f  and h). A much smaller increase was 
seen in 25-RA cells (Fig.  11, b and d). When these experi- 
ments  were performed with  CT60 cells,  identical  results 
were obtained (data not shown). 
To further examine the intracellular location of the accu- 
mulated cholesterol, CT60 cells were costained with filipin 
and lgp58, a monoclonal antibody prepared against a CHO 
cell  lysosomal/endosomal  fraction  (Mellman,  I.,  unpub- 
lished data and personal communication). As seen in Fig. 
12, a  and b, the filipin (Fig.  12 a) signal colocalized with 
the signal obtained with the lysosmal/endosomal antibody 
via indirect immunofluorescence (Fig. 12 b). when the dou- 
ble staining experiment was performed with cells grown in 
delipidated serum medium alone, the filipin staining for 25- 
RA and CT60 resembled that shown in Fig. 11, while the an- 
tibody staining had a very similar and faint fluorescence for 
both cell types (data not shown).  Results using CT52 cells 
were very similar to those shown using CT60 cells (data not 
shown). Control experiments with the nonspecific antibody 
MOPC-21 revealed faint uniform staining over the entire cell 
in all three cell types. 
Discussion 
This report describes a selection procedure for isolating mu- 
tant cells that are resistant to cholesterol starvation.  These 
mutants,  which we have termed cholesterol trafficking, or 
CT mutants, were shown to accumulate a large amount ofun- 
esterified cholesterol  when  grown  in  medium  containing 
LDL (Fig. 9) or 10% FCS. The data indicate that the excess 
cholesterol is located in intracellular particles shown by DIC 
(Fig. 3) and phase-contrast microscopy (Fig. 11). These par- 
ticles are lysosomes and/or endosomes based on fluorescent 
microscopy studies with acridine orange (Fig. 11) and a lyso- 
somal/endosomal monoclonal antibody (Fig.  12).  The high 
cholesterol levels seen in the CT mutants when they were 
grown in LDL were found to decrease dramatically after 2 d 
of growth in delipidated  serum medium (data not shown). This 
observation suggests that the cholesterol was able to leave the 
lysosomes of the CT mutants, perhaps via a nonspecific pro- 
cess (i.e., monomer diffusion, membrane recycling, etc.). 
The ability of the cholesterol to escape from the lysosomes 
probably provided the CT cells with the cholesterol needed 
for survival during the starvation selection. 
In the selection protocol, the number of mutagenized cells 
present in each dish at the start of the cholesterol starvation 
was ,x,l.5  x  105. Since every dish had at least one CT-like 
colony, the lowest possible frequency of this mutant pheno- 
Figure  12.  Indirect  immunofluorescence of filipin-stained CT60 
cells using a lysosomal/endosomal specific antibody. CT60 cells 
were grown as described in Fig. 3 in medium containing 5 % delipi- 
dated serum plus 100/zg/ml of LDL. Cells were fixed, stained with 
filipin, and then stained by indirect immunofuorescence with lgp58 
as detailed in Materials and Methods. a  and b show filipin and 
lgp58 fuorescence, respectively. Bar, 20 tzm. 
type was  •6.6  X  10  -6.  However, more than one CT-like 
colony was always seen and our protocol only identified the 
largest and most obvious surviving colonies. The actual fre- 
quency was probably between 2  x  10  -5 (three independent 
CT  mutants/dish)  and  1  x  10  -4  (15  CT  mutants/dish). 
These frequencies are 2-12 times higher than the frequency 
of obtaining ACAT revertants using an alternative method 
(12),  which  might explain why no ACAT  revertants were 
found in the starvation selections. 
The frequencies of mutation in mutagenized CHO cells 
have commonly been found to range from 1 x  10  -3 to 5  × 
10-  5 for single genes (13, 21, 34, 41, 56), and 1 x  10-6 to 2 
>(  10  -7 for genes that are functionally diploid (11, 21,  34, 
41).  Thus, it appears that the generation of the CT mutant 
phenotype may only have required the mutation of a single 
gene. The data in Fig. 6 indicated that the mutations in CT52 
and CT60 are recessive, suggesting that there is only one ac- 
tive CT gene in the CHO cell line, 25-RA. 
One  phenomena  which  occurred frequently throughout 
the biochemical analysis of the CT mutants was the higher 
than normal  (i.e.,  25-RA)  activities of some of the com- 
monly assayed processes of cholesterol metabolism, such as 
LDL receptor (Figs. 7 and 8) and ACAT activity (Table I), and 
the incorporation of labeled acetate into cholesterol (data not 
shown).  The elevated reconstituted ACAT activity seen in 
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tion since it is never observed in CT60 cells. Unlike ACAT, 
the LDL receptor has been demonstrated to be subject to 
stringent regulation at the level of transcription (27),  and 
3-hydroxy-3-methylgluCa-yl-coenzyme A reduetase,  a rate lim- 
iting enzyme in cholesterol biosynthesis, has been shown to 
be highly regulated at both the transcriptional and posttranla- 
tional levels by cholesterol (27). It is possible that a mutation 
in a cholesterol transport process such as the one affected in 
the CT mutants may alter this complicated regulatory ap- 
paratus and cause an elevation of  these activities. Once rever- 
tants of the CT mutants have been isolated and characterized, 
these possibilities can be more directly examined. 
The microsomal ACAT  specific activity of cell extracts 
normally reflects the values obtained in intact cells with the 
[3H]oleate pulse (15, 16).  In Table I  this was true for the 
cell extracts harvested after growth  in  delipidated  serum 
medium or after 2 h in medium containing LDL. However, 
CT mutants grown for 48 h in LDL had microsomal ACAT 
specific activities as high or higher than 25-RA cell extracts, 
in contradiction to the [3H]oleate pulse data (Fig. 5). These 
high activities may be an artifact of  the preparation of  the cell 
extracts, which involved hypotonic shock (20) that may have 
disrupted the cholesterol loaded lysosomal/endosomal com- 
partments in the CT cells. This cholesterol could then act as 
a  substrate  for ACAT. This type of phenomena has  been 
reported in NP-C fibroblasts (54). 
Previously, it has been shown that the suppression of the 
LDL receptor and cholesterol biosynthesis by LDL occurred 
with  a  significant  lag  in  NP-C  fibroblasts  compared  to 
unaffected fibroblasts (37, 45), consistent with the defective 
movement of cholesterol out of the NP-C lysosomes (38). 
These experiments were attempted with the CT mutants but 
the results were ambiguous because the parental cell line, 25- 
RA, is partially resistant to suppression of cholesterol bio- 
synthesis  and  the  LDL  receptor  pathway  by  exogenous 
sterols (19, and data not shown). Perhaps a significant lag in 
~e kinetics of LDL-mediated suppression of these pathways 
would be evident if the CT mutants were in a wild-type CHO 
cell genetic background.  It should be pointed out that the 
LDL receptor pathway is two to three times more active in 
25-RA cells treated with 58-035 than wild-type cells (11). 
Therefore, a CT mutant derived from a wild-type cell might 
not accumulate as much intracellular unesterified cholesterol 
and thus would not survive as well (if at all) during the star- 
vation selection. 
The exact biochemical process defective in the CT mutants 
is not known. One obvious candidate would be an inactivated 
intracellular cholesterol transporter. Sterol carrier protein2 
is a 13-kD protein originally identified in rat and bovine liver 
cytosol. This protein has been shown to transfer cholesterol 
between membranes in vitro and to activate ACAT activity 
in vitro (25, 48).  Sterol carder protein2 has been localized 
predominantly to peroxisomes in liver (33, 57) but it is pres- 
ent in smaller amounts in the endoplasmic reticulum and 
cytosol (33). The development of  a reliable assay for this pro- 
tein in CHO cells would allow direct testing of whether sterol 
carrier protein2  activity is present in  CT mutant cell ex- 
tracts. 
The defect in the CT mutants does not necessarily have to 
be in a cytosolic  cholesterol transporter. There could be a de- 
fect in the mobilization of the newly hydrolyzed cholesterol 
in the lysosomal interior, or a defect in a receptor molecule 
that receives the cholesterol after transport from the lyso- 
somes. More knowledge concerning the structure and poly- 
peptide composition of the cholesterol loaded lysosomes, 
and the normal pathways of LDL-derived cholesterol trans- 
port out of the lysosomes will be beneficial towards under- 
standing the exact molecular defect in the CT mutants. 
In conclusion,  this paper reports the isolation of CHO 
cells in which the intracellular movement of LDL-derived 
cholesterol is defective, leading to an accumulation of cho- 
lesterol in acidic compartments that are most likely lyso- 
somes. The phenotype of the CT mutants is almost identical 
to that of the NP-C fibroblasts and a strain of BALB/c mice 
with a  similar neurological disorder. The value of the CT 
mutants  is  that  CHO  cells  are  much  more  amenable  to 
genetic manipulation than primary cultures of human fibro- 
blasts or mice. The isolation of a large number of recessive 
CT mutants will allow complementation analysis to deter- 
mine if the inactivation of more than one gene can generate 
a CT phenotype. The ability to fuse CHO cells with human 
fibroblasts  and  the  subsequent  segregation  of the  human 
chromosomes could provide a  means  for  identifying the 
chromosome where the human homologue of the CT gene 
(or genes) is located. In addition, fusions between the CT 
mutants and NP-C firboblasts and biochemical analysis of 
the hybrids could determine if the same locus is affected (no 
complementation observed). The final advantage of obtain- 
ing the cholesterol trafficking phenotype in a CHO genetic 
background, and perhaps the most important, is that exoge- 
nous DNA can be introduced into CHO cells via DNA medi- 
ated gene transfer (1). The complementation of the CT mu- 
tation via transfection of exogenous DNA should be possible 
provided a suitable selection system can be developed. Once 
transformants are obtained, the cloning of the complement- 
ing gene should be possible. Such work is currently under- 
way in our laboratory. 
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